Very Late Stent Thrombosis Due to Multiple Stent Fracture and Stent Malapposition
Zhe-yong HUANG,Ju-ying QIAN,Jun-bo GE
DOI: https://doi.org/10.3760/cma.j.issn.0366-6999.20121539
IF: 6.133
2013-01-01
Chinese Medical Journal
Abstract:Coronary stent fracture (SF) is a rare but potentially serious complication of coronary artery stenting. Here we report a case of acute myocardial infarction as a consequence of very late in-stent thrombosis due to multiple stent fractures at 8 sites and multiple stent malapposition formation four years after a sirolimus-eluting stent implantation (Firebird, Microport, Shanghai, China). A 43-year-old man with hyperlipidemia and a smoking history was referred for coronary angiography (CAG) following repeated exertion associated chest pain in January 2007. CAG revealed a diffused tortuous stenosis at the proximal segment and a total occlusion at the mid-segment of the left anterior descending (LAD) artery, a 90% stenosis at the proximal segment of the left circumflex artery (LCX), and a diffused lesion with a maximal 60% stenosis of the right coronary artery (RCA). The LAD lesion was treated with two overlapping sirolimus-eluting stents (Firebird, Microport, 2.5 mm × 33 mm and 3.0 mm × 33 mm) at 1215.9 kPa (12 atmospheres (ATM)). The LCX lesion was treated with a 3.0 mm × 23 mm Firebird stent at 1215.9 kPa (12 ATM). A good angiographic result was achieved (Figure 1), and he was discharged home in stable condition.Figure 1. A:: Coronary angiogram shows a significant tortuous stenosis at the proximal left anterior descending (LAD) artery and a total occlusion at mid-segment LAD. B: Revascularization with 2.5 mm × 33 mm and 3.0 mm × 33.0 mm sized sirolimus-eluting stents from the middle to the proximal LAD is shown. C: The final CAG obtained before contrast material administration shows no separation between struts.Because of gastrorrhagia, aspirin and ticlopidine were discontinued in May 2007 and March 2011, respectively. Serial follow-up coronary multislice computed tomography (MSCT) images were undertaken on 5 July 2007 and 18 August 2009. MSCT images showed the deteriorating evolution of a stent fracture (SF) in the LAD from two locations in the distal stent, to eight locations in both stents, but no significant in-stent restenosis (ISR) (Figure 2A and 2B). The patient was still in a stable condition without episodes of chest discomfort.Figure 2.: Serial follow-up coronary MSCT images show the evolution of stent fractures in the LAD. A: Six months after the first PCI, the MSCT image showed the loss of continuity with complete strut separation in two different locations of the distal stent (arrows), and only suspected fractures in the proximal stent. B, C: Thirty-one and 55 months after the first PCI, MSCT images showed a more flexible and irregular configuration of the two stents with eight fractures (arrows) and sites of malapposition (arrowheads), but no significant in-stent restenosis in the LAD. D: Six months after re-stenting within the original stents, MSCT image showed the absence of both stent strut separation and malapposition (arrowheads).On 5 September 2011, the patient presented with chest pain that lasted for four hours and was provoked by emotional agitation and not relieved by sublingual nitroglycerin administration. Then he was sent to a local hospital. An electrocardiogram showed significant ST-segment elevation in leads V1- 4, I and aVL. Emergent CAG demonstrated the presence of stent thrombosis- induced total occlusion of the middle LAD. After failing to advance a wire through the turning point caused by the SF at mid-LAD, coronary intervention was aborted. He was then referred to our hospital. After anti coagulation and intensified antiplatelet therapy (clopidogrel, aspirin and IIa/IIIb inhibitor) for several days, MSCT images (64-MSCT, Aquillion® 64, Toshiba Medical Systems, Tokyo, Japan) were taken on 13 September 2011 to classify the distortion and SF, and we found similar results as that of 18 August 2009 (Figure 2C). On 15 September 2011, CAG revealed TIMI III flow in the patency LAD and sharply defined, protruding thorn-like pouches on both sides of the vessel wall in the middle segment, indicating late acquired incomplete stent apposition (Figure 3B). Multiple fluoroscopic images before contrast material administration revealed four obvious gaps in the two overlapping stents indicating multiple complete SFs (Figure 3C). Intravascular ultrasound (IVUS) images (Atlantis 3.0F, 40 MHz coronary imaging catheter, SCIMED, Boston Scientific Corporation, USA) of the LAD revealed complete SFs at five different sites, incomplete SFs at three different sites, stent malapposition and microaneurysm formation at multiple sites, and severe circular calcification at the distal segment of the stents, while there was no evidence of neointimal hyperplasia or instent binary restenosis (Figure 4). Predilatation of the fracture sites were performed with a 2.5 mm × 20.0 mm balloon. We deployed 3.0 mm × 30.0 mm and 3.5 mm × 30.0 mm Endeavor stents (Medtronic CardioVascular, Santa Rosa, CA, USA) covering SF positions at 1418.6 kPa (14 ATM). The mid-portion of the stented segment was then postdilated with the 3.0 mm × 30.0 mm stent balloon at 1418.6 kPa (14 ATM). A good angiographic result was obtained, and confirmed by IVUS examination (Figure 5). Six months after re-stenting within the original stents, he was asymptomatic, and follow-up MSCT images showed the absence of stent strut separation and the presence of mild malapposition phenomenon (Figure 2D).Figure 3. A:: Conventional coronary angiogram shows mid-LAD in-stent total occlusion with thrombosis (black arrowheads). B: After anticoagulation and intensified antiplatelet therapy for several days, angiogram showed the patency LAD and thorn-like pouches on both sides of the vessel wall at the mid-segment, indicating stent malapposition (white arrowheads). C: Angiogram obtained before contrast material administration depicts multiple fracture lines (arrows) in the two stents, indicating multiple complete stent fractures.Figure 4.: Intravascular ultrasound (IVUS) images of LAD reveal complete stent fractures at five different sites, incomplete stent fractures at three different sites, stent malapposition and microaneurysm formation at multiple sites (arrowheads), and severe circular calcification at the distal segment of the stents (K, L), without evidence of neointimal hyperplasia and instent binary restenosis.Figure 5.: Angiographic images of the LAD after the second PCI with two Endeavor stents deployment show the absence of stent strut separation (A) and fewer sites with stent malapposition (B).The present case illustrated multiple complications of drug-eluting stent (DES) in one patient, including multiple SF, stent thrombosis and multiple stent malapposition formation. Coronary SF is a rare but potentially serious complication of coronary artery stenting. In our case, coronary stents experienced multiple fractures at up to eight sites. Probable causes were the long overlapping sirolimus-eluting stents, severe circular calcification at the distal stent, a tortuous vessel, hyperbobility and“milking” of the medial segment of the LAD1. While the mechanism of ST is yet to be completely understood, SF and/or late acquired stent apposition (ISA) could set the stage for late stent thrombosis (LST).2 Firstly, exposure of a free metal strut after fracture into the vessel lumen could trigger platelet activation, stent thrombosis. and subsequent myocardial infarction.2 Secondly, a IVUS study revealed late-acquired stent malapposition was highly prevalent in patients with LST after DES implantation,3 suggesting that there may be an association between late stent malapposition and LST. Finally, a vicious cycle between stent malapposition and SF has been proposed.4 Some types of late-acquired stent malapposition are caused by positive vessel remodeling due to biological reactions to the DES, which may allow motion and/or kinking of the stent, leading to SF. Alternatively, SF can lead to local mechanical irritation of the vessel, which may lead to stent malapposition. In this case, LST might arise by the combination of such interacting structural changes of the vessel and discontinuation of anti-platelet therapy. We should consider alternative anticoagulant therapy such as heparin in cases involving the MSCT findings requiring discontinuation of anti-platelet therapy. Although the long-term follow-up results of SF after drug-eluting stent implantation show an increased risk of adverse cardiac events, there continues to be no uniform consensus regarding the best treatment methods for SF. Stenting, even without angiographic restenosis, has also been reported, because repeat stent placement in the region of the SF appears to provide immediate symptom relief.5 However, which type of stent is optimal still needs to be studied. Additionally, we advocate intensified and prolonged antiplatelet therapy in such cases, as the presence of multiple and severe complications of stents should lead to more aggressive clinical decisions.1